Skip to content
Thursday 20 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,717.78
-0.24%
DAX
25,977.10
-0.44%
CAC 40
8,465.96
-0.42%
STOXX 50
6,424.85
-0.30%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 16 February 2022 8:40 am

AIDS scientists cure human for the first time: Former HIV patient is off medication, asymptomatic and healthy

By: Michiel Willems

Add as a preferred source on Google

Researchers in the U.S. have said they have cured HIV in a human being for the very first time.

The scientists said the mixed-race New York woman, who was previously HIV positive, was now “off medication, asymptomatic and healthy”, according to various media reports.

The scientists reportedly used a cutting-edge stem cell transplant method that they expect will expand the pool of people who could receive similar treatment to several dozen annually.

“The patient stepped into a rarified club that includes three men whom scientists have cured, or very likely cured, of HIV. Researchers also know of two women whose own immune systems have, quite extraordinarily, apparently vanquished the virus,” according to NBC News.

Carl Dieffenbach, director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, one of multiple divisions of the National Institutes of Health that funds the research network behind the new case study, told NBC News that the accumulation of repeated apparent triumphs in curing HIV “continues to provide hope.” 

“It’s important that there continues to be success along this line,” he said.

“We are very excited” about the new case of possible HIV cure, said Dr. Deborah Persaud, a paediatric infectious disease specialist at the Johns Hopkins University School of Medicine who chairs the NIH-funded scientific committee behind the new case study, the International Maternal Pediatric Adolescent AIDS Clinical Trials Network.

However, Persaud did stress the stem cell treatment method is “still not a feasible strategy for all but a handful of the millions of people living with HIV.”

Read more

Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Pharmaceuticals
  • Pharmaceuticals

Trending Articles

  • Jobless Banquet: Youth unemployment surge ‘sends Neets to KFC’

  • City law firm sues prominent Emirati business family

  • Amanda Blanc has worked her magic at Aviva

  • As it happened: Miners fuel FTSE 100 recovery; oil jumps as Trump claims Strait of Hormuz

  • House prices in wealthy London boroughs fall by up to £300,000

More from Morning Wire

  • Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

    Business Wire
  • Grindr for Equality Commits to Connecting 10M to HIV Prevention by 2028

    Business Wire
  • ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

    Business Wire
  • Promega Achieves 100% Renewable Electricity Across Global Operations

    Business Wire
  • Sweeping job cuts at GSK to fund £400m Cambridge campus

    Pharma
    Modern GSK Cambridge campus buildings with sky bridge, green spaces, and people walking and cycling.
  • Picky Brits: Heatwave fuels surge in finger food spending

    Retail
    Tesco quiche, cured meats, olives, and dip on a wooden board, ready for a party or meal.
  • Astrazeneca and Jaguar Land Rover given power to endorse talented migrants for visas

    Politics
    Jonathan Reynolds addressing the SMMT's annual International Automotive Summit (image courtesy of SMMT)
  • It’s hard to picture a more nightmarish vision of our AI future than this

    AI
    Stack of diverse books showcasing various genres and authors, illustrating the articles focus on literary diversity and tr...
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook